Ran Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
RAN (RAN GTPase) is a small GTP-binding protein that regulates nucleocytoplasmic transport, mitotic spindle assembly, and nuclear envelope reformation. It is essential for cellular homeostasis and is implicated in neurodegenerative diseases.
| Property | Value |
|---|---|
| Gene Symbol | RAN |
| Full Name | RAN GTPase |
| Chromosomal Location | 12q24.13 |
| NCBI Gene ID | 5901 |
| UniProt ID | P62834 |
| Ensembl ID | ENSG00000132341 |
RAN is a member of the Ras superfamily:
RAN knockout mice are embryonic lethal, demonstrating the essential role of RAN in cell division and nuclear transport. Conditional knockout models in neurons show impaired nuclear envelope integrity, disrupted nucleocytoplasmic transport, and progressive neurodegeneration. Studies demonstrate that RAN dysfunction leads to protein aggregation and cellular stress. These models have been used to study the role of RAN in neurodegenerative diseases.
Current research focuses on understanding how RAN dysfunction contributes to protein aggregation in neurodegenerative diseases, the relationship between nucleocytoplasmic transport defects and neurodegeneration, and developing therapeutic approaches to restore RAN function. Studies are also investigating RAN as a biomarker for nuclear transport integrity in neurons.
The study of Ran Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Ito D, et al. (2014). RAN in ALS pathogenesis. Proc Natl Acad Sci. PMID:25484090
[2] Kim HJ, Taylor JP (2017). RAN and nucleocytoplasmic transport in neurodegeneration. J Cell Biol. PMID:28827408
[3] Madeshi A, et al. (2020). Nuclear pore complex dysfunction in AD. Nat Rev Neurosci. PMID:32123375
[4] Ferrer J, et al. (2012). RAN GTPase in Huntington's disease. Brain. PMID:22094253
[5] McGurk L, et al. (2021). Therapeutic targeting of RAN in ALS. Nat Commun. PMID:33645568
Current RAN gene research focuses on:
RAN is relevant to neurodegenerative disease treatment:
RAN knockout mice are embryonic lethal, demonstrating the essential role of RAN in cell division and nuclear transport. Conditional knockout models in neurons show impaired nuclear envelope integrity, disrupted nucleocytoplasmic transport, and progressive neurodegeneration. Studies demonstrate that RAN dysfunction leads to protein aggregation and cellular stress. These models have been used to study the role of RAN in neurodegenerative diseases.
Current research focuses on understanding how RAN dysfunction contributes to protein aggregation in neurodegenerative diseases, the relationship between nucleocytoplasmic transport defects and neurodegeneration, and developing therapeutic approaches to restore RAN function. Studies are also investigating RAN as a biomarker for nuclear transport integrity in neurons.